A detailed history of Luts & Greenleigh Group, Inc transactions in Amgen Inc stock. As of the latest transaction made, Luts & Greenleigh Group, Inc holds 671 shares of AMGN stock, worth $194,522. This represents 0.21% of its overall portfolio holdings.

Number of Shares
671
Previous 661 1.51%
Holding current value
$194,522
Previous $207 Million 4.68%
% of portfolio
0.21%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$309.38 - $337.38 $3,093 - $3,373
10 Added 1.51%
671 $216 Million
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $173,677 - $211,063
661 New
661 $207 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Luts & Greenleigh Group, Inc Portfolio

Follow Luts & Greenleigh Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Luts & Greenleigh Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Luts & Greenleigh Group, Inc with notifications on news.